POLYNOVO LTD (PNV.AU) saw its stock price surge by 5.39% during intraday trading on Monday, driven by the company's announcement of strong sales figures.
The medical device company reported Hy Group sales of A$68.2M, signaling robust financial performance and growth prospects. This positive sales update likely fueled investor confidence, leading to the significant price increase.